Список литературы

1. PDQ Pediatric Treatment Editorial Board. Unusual Cancers of Childhood Treatment : Health Professional Version//PDQ Cancer Information Summaries. 2020.

2. Ayan I., Kaytan E., Ayan N. Childhood nasopharyngeal carcinoma: from biology to treatment.//The Lancet. Oncology. Lancet Publishing Group, 2003. Vol. 4, N 1. P. 13 - 21.

3. Sultan I. et al. Differential features of nasopharyngeal carcinoma in children and adults: A SEER study//Pediatr. Blood Cancer. 2010. Vol. 55, N 2. P. 279 - 284.

4. Richards M.K. et al. Factors associated with mortality in pediatric vs adult nasopharyngeal carcinoma//JAMA Otolaryngol. - Head Neck Surg. American Medical Association, 2016. Vol. 142, N 3. P. 217 - 222.

5. Liu Z. et al. Cancer risk in the relatives of patients with nasopharyngeal carcinoma - A register-based cohort study in Sweden//Br. J. Cancer. Nature Publishing Group, 2015. Vol. 112, N 11. P. 1827 - 1831.

6. Song C., Yang S. A meta-analysis on the EBV DNA and VCA-IgA in diagnosis of Nasopharyngeal Carcinoma//Pakistan Journal of Medical Sciences. Professional Medical Publications, 2012. Vol. 29, N 3. P. 885.

7. Hu S. et al. Prognostic factors and long-term outcomes of nasopharyngeal carcinoma in children and adolescents//Pediatr. Blood Cancer. 2013. Vol. 60, N 7. P. 1122 - 1127.

8. Kontny U. et al. Diagnosis and Treatment of Nasopharyngeal Carcinoma in Children and Adolescents - Recommendations of the GPOH-NPC Study Group//Klin. Padiatr. Georg Thieme Verlag, 2016. Vol. 228, N 3. P. 105 - 112.

9. Yan Z. et al. Nasopharyngeal carcinoma in children and adolescents in an endemic area: A report of 185 cases//Int. J. Pediatr. Otorhinolaryngol. Elsevier, 2013. Vol. 77, N 9. P. 1454 - 1460.

10. Erdlenbruch B. et al. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: Its correlation with p53 and bcl-2 expression//Med. Pediatr. Oncol. 2002. Vol. 38, N 5. P. 345 - 348.

11. Cao K. et al. Prognostic Factors in Nasopharyngeal Carcinoma in Childhood and Adolescence//Zhonghua Zhong Liu Za Zhi. 2006. Vol. 28, N 2. P. 134 - 137.

12. Turgut M. et al. Importance of cranial nerve involvement in nasopharyngeal carcinoma. A clinical study comprising 124 cases with special reference to clinical presentation and prognosis//Neurosurg. Rev. Neurosurg Rev, 1998. Vol. 21, N 4. P. 243 - 248.

13. Tabuchi K. et al. Early detection of nasopharyngeal carcinoma//Int. J. Otolaryngol. 2011. P. 638058.

14. Ho H.C. et al. Epstein-barr-virus-specific iga and igg serum antibodies in nasopharyngeal carcinoma//Br. J. Cancer. Nature Publishing Group, 1976. Vol. 34, N 6. P. 655 - 660.

15. Licciardello M., Pegoraro A., Cesaro S. Prophylaxis and therapy of viral infections in pediatric patients treated for malignancy//Pediatr. Rep. PAGEPress, 2011. Vol. 3, N 1.

16. Детская онкология. Национальное руководство. Под ред. М.Д. Алиева, В.Г. Полякова, Г.Л. Менткевича, С.А. Маяковой. М.: Издательская группа РОНЦ. Практическая медицина, 2012. 684 p.

17. Chao T.Y. et al. Imprint cytology of nasopharyngeal biopsies//Acta Cytol. Acta Cytol, 1996. Vol. 40, N 6. P. 1221 - 1226.

18. Chiesa F., De Paoli F. Distant Metastases from Nasopharyngeal Cancer//ORL. Karger Publishers, 2001. Vol. 63, N 4. P. 214 - 216.

19. Cvitkovic E. et al. Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: A review of 255 consecutive cases//J. Clin. Oncol. Lippincott Williams and Wilkins, 1993. Vol. 11, N 12. P. 2434 - 2442.

20. Freilich R.J., Krol G., Deangelis L.M. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis//Ann. Neurol. John Wiley & Sons, Ltd, 1995. Vol. 38, N 1. P. 51 - 57.

21. Shi S.R. et al. Immunohistochemical study of nasopharyngeal carcinoma using monoclonal keratin antibodies//Am. J. Pathol. American Society for Investigative Pathology, 1984. Vol. 117, N 1. P. 53 - 63.

22. Tseng Y.-L., Liao L.-J. Ultrasonography in the Diagnosis and Follow-up of Nasopharyngeal Carcinoma.

23. Kapoor A. et al. Detection of bone metastasis in nasopharyngeal carcinoma by bone scintigraphy: A retrospective study in perspective of limited resource settings//Clin. Cancer Investig. J. Medknow, 2015. Vol. 4, N 1. P. 17.

24. Low W.K. Middle ear pressures in patients with nasopharyngeal carcinoma and their clinical significance.//J. Laryngol. Otol. 1995. Vol. 109, N 5. P. 390 - 393.

25. Lin C. et al. Risk of developing sudden sensorineural hearing loss in patients with nasopharyngeal carcinoma: A population-based cohort study//Head Neck. Head Neck, 2014. Vol. 36, N 2. P. 203 - 208.

26. Druker H. et al. Genetic counselor recommendations for cancer predisposition evaluation and surveillance in the pediatric oncology patient//Clin. Cancer Res. American Association for Cancer Research Inc., 2017. Vol. 23, N 13. P. e91 - e97.

27. Горбунова Т.В. et al. Анализ результатов лечения пациентов детского возраста с раком носоглотки: ретроспективное когортное исследование//Онкопедиатрия. 2018. Vol. 4, N 5. P. 257 - 268.

28. Ribassin-Majed L. et al. What is the best treatment of locally advanced nasopharyngeal carcinoma? an individual patient data network meta-analysis//J. Clin. Oncol. American Society of Clinical Oncology, 2017. Vol. 35, N 5. P. 498 - 505.

29. Горбунова Т.В. et al. Рак носоглотки//Детская онкология. Клинические рекомендации по лечению пациентов с солидными опухолями, под редакцией М.Ю. Рыкова, В.Г. Полякова. 2017. P. 51 - 73.

30. Beck O. et al. Central venous access devices (CVAD) in pediatric oncology patients - a single-center retrospective study over more than 9 years//Front. Pediatr. Frontiers Media S.A., 2019. Vol. 7, N JUN.

31. Владимирова Л.Ю. et al. Практические рекомендации по профилактике и лечению тошноты и рвоты у онкологических больных//Практические рекомендации Российского общества клинической онкологии. Лекарственное лечение злокачественных опухолей. Поддерживающая терапия в онкологии. 2018. P. 502 - 511.

32. Sherani F., Boston C., Mba N. Latest Update on Prevention of Acute Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients//Current Oncology Reports. Current Medicine Group LLC 1, 2019. Vol. 21, N 10.

33. G. et al. Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: A randomised, phase 3, double-blind, double-dummy, non-inferiority study//Lancet Oncol. Lancet Publishing Group, 2016. Vol. 17, N 3. P. 332 - 344.

34. Ruggiero A., Riccardi R. Interventions for anemia in pediatric cancer patients//Med. Pediatr. Oncol. John Wiley & Sons, Ltd, 2002. Vol. 39, N 4. P. 451 - 454.

35. Robinson D. et al. Evidence-Based Practice Recommendations for Hydration in Children and Adolescents With Cancer Receiving Intravenous Cyclophosphamide//J. Pediatr. Oncol. Nurs. SAGE Publications Inc., 2014. Vol. 31, N 4. P. 191 - 199.

36. August D.A., Huhmann M.B. A.S.P.E.N. Clinical guidelines: Nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation//Journal of Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr, 2009. Vol. 33, N 5. P. 472 - 500.

37. Isenring E., Elia M. Which screening method is appropriate for older cancer patients at risk for malnutrition?//Nutrition. Elsevier Inc., 2015. Vol. 31, N 4. P. 594 - 597.

38. Martin L. et al. Diagnostic criteria for the classification of cancer-associated weight loss//J. Clin. Oncol. American Society of Clinical Oncology, 2015. Vol. 33, N 1. P. 90 - 99.

39. Manary M.J., Sandige H.L. Management of acute moderate and severe childhood malnutrition//BMJ. BMJ, 2008. Vol. 337, N 7680. P. 1227 - 1230.

40. van den Broeck J., Eeckels R., Massa G. Validity of Single-Weight Measurements to Predict Current Malnutrition and Mortality in Children//J. Nutr. 1996. Vol. 126, N 1. P. 113 - 120.

41. Meijers J.M.M. et al. Nutritional care; do process and structure indicators influence malnutrition prevalence over time?//Clin. Nutr. Churchill Livingstone, 2014. Vol. 33, N 3. P. 459 - 465.

42. Muscaritoli M. et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"//Clin. Nutr. Clin Nutr, 2010. Vol. 29, N 2. P. 154 - 159.

43. Kondrup J. et al. ESPEN guidelines for nutrition screening 2002//Clin. Nutr. Churchill Livingstone, 2003. Vol. 22, N 4. P. 415 - 421.

44. Arends J. et al. ESPEN guidelines on nutrition in cancer patients//Clin. Nutr. Churchill Livingstone, 2017. Vol. 36, N 1. P. 11 - 48.

45. Bauer J., H., M.C. Important Aspects of Nutrition in Children with Cancer//Adv. Nutr. Oxford University Press (OUP), 2011. Vol. 2, N 2. P. 67 - 77.

46. Joosten K.F.M., Kerklaan D., Verbruggen S.C.A.T. Nutritional support and the role of the stress response in critically ill children//Current Opinion in Clinical Nutrition and Metabolic Care. Lippincott Williams and Wilkins, 2016. Vol. 19, N 3. P. 226 - 233.

47. Koletzko B. et al. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatri//Journal of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr, 2005. Vol. 41, N SUPPL. 2. 87 p.

48. Абузарова Г.Р. et al. Обезболивание взрослых и детей при оказании медицинской помощи. Методические рекомендации. ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России., 2016. 94 p.

49. Psyrri A. et al. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: Long-term follow-up//J. Clin. Oncol. 2004. Vol. 22, N 15. P. 3061 - 3069.